Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis

INTRODUCTION: To compare the economic benefit of upadacitinib combination therapy versus tofacitinib combination therapy and upadacitinib monotherapy versus methotrexate monotherapy from improvements in health-related quality of life (HRQOL) in patients with rheumatoid arthritis (RA). METHODS: Data...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergman, Martin, Tundia, Namita, Yang, Min, Orvis, Eli, Clewell, Jerry, Bensimon, Arielle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572211/
https://www.ncbi.nlm.nih.gov/pubmed/34636000
http://dx.doi.org/10.1007/s12325-021-01930-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572211/
https://www.ncbi.nlm.nih.gov/pubmed/34636000
http://dx.doi.org/10.1007/s12325-021-01930-4

Ejemplares similares